Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

Published:2023 Issue:45 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Shin Eun-Seok¹^ORCID,Her Ae-Young²^ORCID,Kim Bitna¹^ORCID,Hahn Joo-Yong³^ORCID,Song Young Bin³^ORCID,Lee Joo Myung³^ORCID,Park Taek Kyu³^ORCID,Yang Jeong Hoon³^ORCID,Choi Jin-Ho⁴^ORCID,Choi Seung-Hyuk³^ORCID,Lee Sang Hoon³^ORCID,Gwon Hyeon-Cheol³^ORCID,

Affiliation:

1. Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

2. Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.

3. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

4. Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Funder

Korean Society of Interventional Cardiology

Abbott Vascular, Biotronik, and Boston Scientific

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e383

Reference22 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

2. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy

3. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

4. Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

5. Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation